Found 1129 results
[ Author(Desc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
B
L. E. Bermudez, Covaro, G., and Remington, J., Infection of murine macrophages with Toxoplasma gondii is associated with release of transforming growth factor beta and downregulation of expression of tumor necrosis factor receptors., Infection and immunity, vol. 61, no. 10, pp. 4126-30, 1993.
L. E. Bermudez and Young, L. S., Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex., Journal of immunology (Baltimore, Md. : 1950), vol. 140, no. 9, pp. 3006-13, 1988.
L. E. Bermudez, Panza, M., Velasco, E., and Vidal, E., [Effect of systemic antibiotic therapy on microbial flora of gastrointestinal tract in the hematological patients]., Revista paulista de medicina, vol. 102, no. 6, pp. 256-9, 1984.
L. E. Bermudez and Goodman, J., Mycobacterium tuberculosis invades and replicates within type II alveolar cells., Infection and immunity, vol. 64, no. 4, pp. 1400-6, 1996.
L. E. Bermudez, Use of liposome preparation to treat mycobacterial infections., Immunobiology, vol. 191, no. 4-5, pp. 578-83, 1994.
L. E. Bermudez, Inderlied, C., and Young, L. S., Stimulation with cytokines enhances penetration of azithromycin into human macrophages., Antimicrobial agents and chemotherapy, vol. 35, no. 12, pp. 2625-9, 1991.
L. E. Bermudez, Kolonoski, P., Young, L. S., and Inderlied, C. B., Activity of KRM 1648 alone or in combination with ethambutol or clarithromycin against Mycobacterium avium in beige mouse model of disseminated infection., Antimicrobial agents and chemotherapy, vol. 38, no. 8, pp. 1844-8, 1994.
L. E. Bermudez and Sangari, F. J., Cellular and molecular mechanisms of internalization of mycobacteria by host cells., Microbes and infection / Institut Pasteur, vol. 3, no. 1, pp. 37-42, 2001.
L. E. Bermudez and Young, L. S., Ethanol and survival of Mycobacterium avium complex within macrophages., Progress in clinical and biological research, vol. 325, pp. 383-91, 1990.
L. E. Bermudez, Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide., Clinical and experimental immunology, vol. 91, no. 2, pp. 277-81, 1993.
L. E. Bermudez and Martins, C. A., [Non-traumatic Clostridium infections]., AMB : revista da Associação Médica Brasileira, vol. 33, no. 1-2, pp. 38-9, 1987.
L. E. Bermudez, Wu, M., Martinelli, J., and Young, L. S., Ethanol affects release of TNF and GM-CSF and membrane expression of TNF receptors by human macrophages., Lymphokine and cytokine research, vol. 10, no. 5, pp. 413-9, 1991.
L. E. Bermudez, Effect of ethanol on the interaction between the macrophage and Mycobacterium avium., Alcohol (Fayetteville, N.Y.), vol. 11, no. 2, pp. 69-73, 1994.
L. E. Bermudez, Yau-Young, A. O., Lin, J. P., Cogger, J., and Young, L. S., Treatment of disseminated Mycobacterium avium complex infection of beige mice with liposome-encapsulated aminoglycosides., The Journal of infectious diseases, vol. 161, no. 6, pp. 1262-8, 1990.
L. E. Bermudez, Petrofsky, M., Wu, M., and Young, L. S., Clarithromycin significantly improves interleukin-12-mediated anti-Mycobacterium avium activity and abolishes toxicity in mice., The Journal of infectious diseases, vol. 178, no. 3, pp. 896-9, 1998.
L. E. Bermudez, Young, L. S., Martinelli, J., and Petrofsky, M., Exposure to ethanol up-regulates the expression of Mycobacterium avium complex proteins associated with bacterial virulence., The Journal of infectious diseases, vol. 168, no. 4, pp. 961-8, 1993.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Wu, M., Aralar, P., and Young, L. S., Telithromycin is active against Mycobacterium avium in mice despite lacking significant activity in standard in vitro and macrophage assays and is associated with low frequency of resistance during treatment., Antimicrobial agents and chemotherapy, vol. 45, no. 8, pp. 2210-4, 2001.
L. E. Bermudez, Stevens, P., Kolonoski, P., Wu, M., and Young, L. S., Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor., Journal of immunology (Baltimore, Md. : 1950), vol. 143, no. 9, pp. 2996-3000, 1989.
L. E. Bermudez, Petrofsky, M., and Sangari, F., Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype., Cell biology international, vol. 28, no. 5, pp. 411-9, 2004.
L. E. Bermudez, Wu, M., Young, L. S., and Inderlied, C. B., Postantibiotic effect of amikacin and rifapentine against Mycobacterium avium complex., The Journal of infectious diseases, vol. 166, no. 4, pp. 923-6, 1992.
L. E. Bermudez, The use of monoclonal antibodies in the diagnosis of partially treated Pseudomonas aeruginosa meningitis: patient report., Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica .. [et al.], vol. 19, no. 2, pp. 159-65, 1986.
L. E. Bermudez, Petrofsky, M., and Shelton, K., Epidermal growth factor-binding protein in Mycobacterium avium and Mycobacterium tuberculosis: a possible role in the mechanism of infection., Infection and immunity, vol. 64, no. 8, pp. 2917-22, 1996.
L. E. Bermudez and Young, L. S., Natural killer cell-dependent mycobacteriostatic and mycobactericidal activity in human macrophages., Journal of immunology (Baltimore, Md. : 1950), vol. 146, no. 1, pp. 265-70, 1991.
L. E. Bermudez, Motamedi, N., Chee, C., Baimukanova, G., Kolonoski, P., Inderlied, C., Aralar, P., Wang, G., Phan, L. Tam, and Young, L. S., EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 51, no. 5, pp. 1666-70, 2007.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., Aralar, P., Wu, M., and Young, L. S., Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium., Antimicrobial agents and chemotherapy, vol. 45, no. 1, pp. 217-22, 2001.

Pages